SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.250+0.5%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Finley who wrote (504)11/16/1999 1:41:00 PM
From: RWReeves   of 645
 
The other Question that I have

not been able to answer is why Gilead didn't move on Tamiflu approval and neither did AVIR. Since that's the case, then will it take CORR-like "brute-force-get-to-market-and-sell-the-stuff" to make AVIR rise? What happened to efficient markets discount the future into today and all that?

I like AVIR; it's cheap and getting cheaper for what's there but I grudgingly planning to take the pay-off when AVIR eventually gets munched or starts earning real sales revenues. That's pretty sad, a milestone in this dot-com era.

RWR
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News